Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet
Journal Title: Annals of Hepatology - Year 2011, Vol 10, Issue 4
Abstract
Objective. To evaluate the efficacy of low carbohydrate diet (LCD) as compared with low fat diet (LFD) to decrease aminotransferase levels in obese women with nonalcoholic fatty liver disease. Material and methods. A total of 59 women were randomly enrolled in a non-controlled clinical intervention study to receive either LCD or LFD during six months. Apparently healthy non-pregnant obese women aged 20 to 65 years were eligible to participate. Previous diagnosis of hepatic disease, serum creatinine level ≥ 1.5 mg/dL, severe life-limiting medical illness, pregnancy, active participation in other dietary program, use of weight loss drugs, or alcohol consumption ≥ 30 g per day were exclusion criteria. Results. A total of 31 obese women who received LCD were compared with 28 women allocated in the LFD group. There were 3 (LCD group) and 2 (LFD group) women with lost of follow-up. No differences in the proportion of type 2 diabetes, hypertension and hyperlipidemia were noted between women in the LCD and LFD groups. At end of follow-up, there were not significant statistical differences in the anthropometric and biochemical characteristics between women in both groups. The weight loss was 5.7 and 5.5% for women in the LCD LFD groups. Although the decrease of AST (31.7 and 22.4%) and ALT (41 and 33.3%) levels was more elevated in the women of LCD group, as compared with the LFD group, there were not significant statistical differences. Conclusions. Our results show that weight loss, irrespective of the type of diet, reduces aminotransferase levels in obese women with NAFLD.
Authors and Affiliations
Heriberto Rodríguez-Hernández, Miriam Cervantes-Huerta, Martha Rodríguez-Moran, Fernando Guerrero-Romero
Keywords
Related Articles
- EP ID EP78080
- DOI -
- Views 107
- Downloads 0
Genetic susceptibility to hepatoxicity due to bosentan treatment in pulmonary hypertension
Background. Hepatotoxicity is a major side effect of treatment with bosentan in patients with pulmonary hypertension (PH). Bosentan is metabolized by the cytochrome CYP2C9 and inhibits the bile salt export pump, which is...
Maternal separation on the ethanol-preferring adult rat liver structure
Background and rationale for the study. We designed to test whether there is interaction of maternal separation (MS) on the ethanol-preferring rats liver structure. The UCh rat pups were separated daily from their mother...
Embolization of porto-systemic shunt as treatment for recurrent hepatic encephalopathy
Predicting 6-week mortality after acute variceal bleeding: role of classification and regression tree analysis
Background. Available prognostic scores for mortality after acute variceal bleeding are mainly based on logistic regression analysis but may have some limitations that can restrict their clinical value. Aims. To assess t...
Bile acids and the Risk for Hepatocellular Carcinoma in Primary Biliary Cholangitis
This article does not has abstract.